Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Alector, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ALEC
Nasdaq
2830
www.alector.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Alector, Inc.
Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025
- Jan 13th, 2025 1:00 pm
ALEC Stock Tanks as Alzheimer's Drug Fails in Mid-Stage Study
- Nov 27th, 2024 2:42 pm
Alector price target lowered to $7 from $35 at H.C. Wainwright
- Nov 27th, 2024 11:50 am
Alector stock drops after Alzheimer’s drug fails in Phase II trial
- Nov 26th, 2024 2:00 pm
Alector turns to layoffs as Alzheimer’s drug fails
- Nov 26th, 2024 8:44 am
Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update
- Nov 25th, 2024 9:05 pm
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
- Nov 14th, 2024 9:05 pm
Alector (ALEC) Reports Q3 Loss, Misses Revenue Estimates
- Nov 6th, 2024 10:50 pm
Alector: Q3 Earnings Snapshot
- Nov 6th, 2024 9:43 pm
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update
- Nov 6th, 2024 9:05 pm
Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains?
- Nov 1st, 2024 11:43 am
Is Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans?
- Oct 30th, 2024 12:36 pm
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
- Sep 19th, 2024 12:00 pm
Alector (NASDAQ:ALEC) investors are sitting on a loss of 77% if they invested three years ago
- Sep 19th, 2024 11:04 am
Ascendis Pharma (ASND) Moves 17.1% Higher: Will This Strength Last?
- Sep 17th, 2024 1:02 pm
Alector to Participate in Upcoming Healthcare Conferences
- Aug 29th, 2024 11:00 am
Director Richard Scheller Sells 44,250 Shares of Alector Inc (ALEC)
- Aug 23rd, 2024 11:19 pm
Alector Second Quarter 2024 Earnings: Beats Expectations
- Aug 9th, 2024 10:52 am
Alector (ALEC) Reports Q2 Loss, Lags Revenue Estimates
- Aug 7th, 2024 10:15 pm
Alector: Q2 Earnings Snapshot
- Aug 7th, 2024 9:11 pm
Scroll